Nanoform Finland (STU:4YL) Valuation Rank


STU:4YL Nanoform Finland PLC STU:4YL
67 GF Score
Price €0.75
GF Value €1.77
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Nanoform Finland Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Nanoform Finland Valuation Rank Related Terms

STU:4YL
67GF Score
Nanoform Finland PLC STU:4YL
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nanoform Finland (STU:4YL) Overvalued in 2026?

Based on GuruFocus' analysis, Nanoform Finland stock appears to be undervalued. The current stock price of €0.75 is trading 57.8% below its estimated GF Value™ of €1.77. GuruFocus considers Nanoform Finland to be Possible Value Trap.

Key valuation signals for STU:4YL:

  • Valuation Rank:
  • GF Value™: €1.77 vs. price of €0.75 (57.8% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the STU:4YL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanoform Finland Business Description

Address Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790
Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications. Geographically, the company generates maximum revenue from Europe, followed by the United States and other regions.
67GF Score

Get the complete analysis for STU:4YL

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75
Price
€1.77
GF Value